Why is Guj. Terce Labs. falling/rising?

As of 21-Jul, Gujarat Terce Laboratories Ltd is currently priced at 49.73, reflecting an increase of 0.19 or 0.38%. Despite this slight uptick, the stock has shown a negative performance trend over the past week and month, with declines of 2.45% and 9.58%, respectively. The stock is trading below its moving averages across all time frames, indicating a bearish trend. Additionally, there has been a decrease in investor participation, with delivery volume falling by 1.57% compared to the five-day average. While the stock has generated a return of 7.36% over the past year, it has experienced a significant profit decline of 121%, which raises concerns about its long-term viability. The company's attractive valuation, indicated by a ROCE of 25.4 and a favorable enterprise value to capital employed ratio, contrasts sharply with its weak long-term fundamentals, including a low growth rate in net sales and a high debt to EBITDA ratio. In the broader market context, Gujarat Terce Laboratories Ltd's recent performance has been notably worse than the benchmark, as it has declined by 2.45% over the past week while the Sensex has only fallen by 0.06%. This underperformance in the short term suggests that investor sentiment is cautious, particularly given the company's weak financial indicators and declining profits. The stock's liquidity remains adequate for trading, but the overall market sentiment appears to be influenced by the company's fundamental weaknesses, leading to a cautious outlook among investors.